Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review Thomas S. Huber, MD, PhD, Jeffrey W. Carter, BS, Randy L. Carter, PhD, James M. Seeger, MD Journal of Vascular Surgery Volume 38, Issue 5, Pages 1005-1011 (November 2003) DOI: 10.1016/S0741-5214(03)00426-9
Figure Patency rate (percent patent) for autogenous (Auto) and polytetrafluoroethylene (PTFE) upper extremity arteriovenous hemodialysis accesses plotted against time (months), with positive standard error bars. Both primary (Auto 1, PTFE 1) and secondary (Auto 2, PTFE 2) patency rates for the two access types are shown. Patency rates for autogenous accesses are better than for their corresponding PTFE counterparts, with the one exception of the initial (1.5 months) time point for primary patency comparison. Journal of Vascular Surgery 2003 38, 1005-1011DOI: (10.1016/S0741-5214(03)00426-9)